Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC.
Lancet Haematol. 2016 Apr;3(4):e163-75. doi: 10.1016/S2352-3026(16)00006-5. Epub 2016 Mar 17.
Castleman's disease, pathophysiology, advances in diagnosis and treatment.
Pertusa Mataix R, Loaiza Cabello D, García Morillo JS.
Med Clin (Barc). 2024 Mar 22;162(6):283-290. doi: 10.1016/j.medcli.2023.10.013. Epub 2023 Nov 27.
Osteosclerosis in Castleman's disease.
Liu SZ, Zhou X, Wang YP, Liu Y.
QJM. 2022 Mar 22;115(3):171-172. doi: 10.1093/qjmed/hcac013.
Castleman's disease.
Shahidi H, Myers JL, Kvale PA.
Mayo Clin Proc. 1995 Oct;70(10):969-77. doi: 10.4065/70.10.969.
[Castleman's disease in the rheumatological practice].
Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kötter I, Tiemann M, Backhaus M, Manger B, Hübel K, Müller-Ladner U, Henes J.
Z Rheumatol. 2024 May;83(4):316-326. doi: 10.1007/s00393-023-01393-8. Epub 2023 Aug 25.
Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
Sasaki T, Akiyama M, Kaneko Y, Takeuchi T.
Rheumatology (Oxford). 2022 Feb 2;61(2):490-501. doi: 10.1093/rheumatology/keab634.
Castleman's disease in the left paravertebral region.
Wu J, Lei Q, Wang B, Qiu X.
Asian J Surg. 2023 May;46(5):2079-2080. doi: 10.1016/j.asjsur.2022.11.031. Epub 2022 Nov 19.
Castleman's disease. Update on pathogenesis.
Al-Maghrabi JA.
Saudi Med J. 2011 May;32(5):451-8.
Cutaneous Disorders Associated with Castleman's Disease.
Kim HJ, Han JH, Bang CH, Park KS, Cho SG, Yoo DS, Kim KM, Park HJ, Park YM, Lee JY, Lee JH.
Acta Derm Venereol. 2019 Oct 1;99(11):984-989. doi: 10.2340/00015555-3253.
Castleman's disease: systematic analysis of 416 patients from the literature.
Talat N, Schulte KM.
Oncologist. 2011;16(9):1316-24. doi: 10.1634/theoncologist.2011-0075. Epub 2011 Jul 17.
